Big Pharma vs SPY: returns, Sharpe ratio and drawdown

Performance

Big Pharma+25.13%SPY+11.82%
RETURNS1DYTD1Y5Y Ann.Max DDSharpeDiv. Yield
Big Pharma-2.44%+20.38%+25.13%+15.45%-9.77%1.04—
SPY-0.31%+7.92%+11.82%+10.77%-8.88%0.621.04%

Summary

Big Pharma vs SPY

Over the past year, Big Pharma returned more: +25.13% against +11.82% for SPY. Over five years, Big Pharma returned more: +15.45% a year against +10.77% for SPY. Big Pharma had the higher Sharpe ratio over the past year (1.04 vs 0.62), meaning more return for each unit of volatility. SPY fell less at its worst over the past year: -8.88% from its peak, against -9.77% for Big Pharma. Their daily returns had a correlation of 0.20 over the past year, which is low and below the 0.35 of the past five years (measured on weekly returns).

Ranking

How Big Pharma and SPY rank

Big PharmaSPY
8965
1Y Return Rank
8279
5Y Return Rank
7668
Sharpe Ratio Rank
3563
Max Drawdown Rank
2661
Volatility Rank
—28
Dividend Yield Rank

Current Drawdown

Big Pharma-5.01%SPY-6.28%

Rolling Volatility

Big Pharma23.74%SPY21.93%

METRICS

Correlation Matrix

Big PharmaSPY
Big Pharma1.000.20
SPY0.201.00

Assets

Allocation

Big Pharma
SPY

Metrics

Risk Indicators

Big PharmaSPY

Alpha

Big Pharma
18.40%
SPY
0.00%

Beta

Big Pharma
0.29x
SPY
1.00x

Sharpe

Big Pharma
1.04
SPY
0.62

Sortino

Big Pharma
1.64
SPY
0.86

Omega

Big Pharma
1.18
SPY
1.11

Calmar

Big Pharma
2.57
SPY
1.33

Martin

Big Pharma
4.91
SPY
3.73